PDL BioPharma, Inc. Fair Value of Long-Term Debt
PDL BioPharma, Inc. had Fair Value of Long-Term Debt of $400.18 million as of 2012-06-30, per its 10-Q filed 2012-08-02.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:LongTermDebtFairValue · last filed 2012-08-02
- 2012-06-30: Long-term Debt, Fair Value $400.18M.
- 2012-03-31: Long-term Debt, Fair Value $432.83M.
- 2011-12-31: Long-term Debt, Fair Value $442.83M.
| Period end | Long-term Debt, Fair Value |
|---|---|
| 2012-06-30 | $400.18M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $432.83M 10-Q · filed 2012-05-03 |
| 2011-12-31 | $442.83M 10-Q · filed 2012-08-02 |